Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and PlatinumNeoplasms by Site, Thoracic Neoplasms, lung disorder, lung neoplasm, neoplasm, pulmonary large cell neuroendocrine carcinoma, respiratory system disorder, respiratory tract neoplasmRecruitingPhase 22024-08-02NCT06393816

2 results · Page 1 of 1

Swipe the table sideways for more columns.

31 results · Page 1 of 2

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
APHM, hôpital nordMarseilleFrance1
Centre Francois BaclesseCaenFrance33
Centre Francois MagendiePessacFrance1
Centre Hospitalier d'AvignonAvignonFrance4
Centre Hospitalier de CornouailleQuimperFrance6
Centre Hospitalier Intercommunal Aix-PertuisAix-en-ProvenceFrance1
Centre Hospitalier Intercommunal de CreteilCréteilFrance4
Centre Leon BerardLyonFrance70
Centre Oscar LambretLilleFrance73
CHU Amiens Picardie Site SudAmiensFrance2
CHU AngersAngersFrance48
Chu Annecy GenevoisÉpagnyFrance1
CHU BREST Cavale BlancheBrestFrance1
CHU DupuytrenLimogesFrance13
CHU Gabriel MontpiedClermont-FerrandFrance11
Chu Grenoble AlpesGrenobleFrance27
CHU NiceNiceFrance2
CHU RennesRennesFrance21
Chu ReunionRéunionReunion1
CHU ToulouseToulouseFrance19
GHRMSA, hôpital Emile MullerMulhouseFrance1
Grand Hopital de L'Est Francilien - Site de MeauxMeauxFrance1
Groupe Hospitalier Bretagne SudLorientFrance3
Hia Saint AnneToulonFrance1
Hopital CochinParisFrance20